Tag: biomedicin

Nyheter

Diabetes drug can prevent heart disease

2012-03-16 14:29 GöteborgBIO The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy. Researchers at the University of Gothenburg's Sahlgrenska Academy have shown in a preliminary study in rats that one of the most common diabetes drugs, metformin, also has a protective effect on the heart.

Immunicum includes first patients in phase l/ll of cancer vaccine study

2012-03-12 09:27 GöteborgBIO Immunicum develops vaccines for the therapeutic treatment of cancer. The Gothenburg-based company now includes the first patients in phase l/ll of cancer vaccine study. In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine.

Large study in Gothenburg could save a lot of hearts

2012-02-23 16:59 GöteborgBIO The biggest research study of heart, lung and blood diseases ever to have been carried out in Sweden - SCAPIS - Swedish Cardiopulmonary Bioimage Study - was recently initiated in Gothenburg. A number of regional medical and healthcare operators are going to try and identify individual risk factors for heart attacks, sudden cardiac arrests and other heart diseases.

New Swedish Implant Technique for the USA

2012-02-13 14:18 GöteborgBIO Bone-anchored prostheses for amputees are a pioneering method of treatment that significantly improves the quality of life for an important group of younger disabled individuals. The Gothenburg-based company Integrum recently presented the OPRA implant system — Osseointegrated Prosthetics for the Rehabilitation of Amputees, in the USA.

Revolutionary approach to allergy prevention

2012-02-10 13:55 GöteborgBIO Premune is based on world-leading research in bacteriology and immunology, with 15 years of clinical studies at the University of Gothenburg and Sahlgrenska Academy. Serendipity Innovations AB has initiated an exciting collaboration with Encubator AB regarding the startup company Premune AB, a company that is expected to revolutionize the market with its new approach to allergy prevention.

Gothenburg stem cell researcher awarded grant from Hjärnfonden (Swedish Brain Foundation)

2012-01-23 15:53 GöteborgBIO Hjärnfonden collects donations and supports research about the whole brain and nervous system. Charlotta Lindwall, at the University of Gothenburg, receives SEK 280,000 for her research into stem cells.

Transplantation research moves to Sahlgrenska Science Park

2012-01-03 12:17 GöteborgBIO Transplantation related research is being organised in a completely new way within Transplantation Biology & Regenerative Medicine at the Transplantation Centre at Sahlgrenska University Hospital in Göteborg. The new concept is based on the purpose of transferring knowledge from research to patient as quickly as possible. The center now moves to Sahlgrenska Science Park offering ideal premises.

Award to Medfield Diagnostics

2011-11-18 11:55 GöteborgBIO Göteborg based Medfield Diagnostics is winner of National Instruments yearly "NI Graphical Systems Design Awards" in Sweden 2011. Medfield's first product, Strokefinder R10, is an instrument for researchers within stroke and neurological research and can be used both for snapshot measurements to differentiate between ischemic and hemorrhagic stroke as well as to monitor changes over time.

Gold Medallion Award for Professor Tomas Albrektsson

2011-09-26 16:07 GöteborgBIO Professor Tomas Albrektsson receives the Gold Medallion Award from the American Prosthodontic Society. He has also been elected honorary member of the British Society for Specialist Prosthodontic Disciplines. Prof. Albrektsson is Head of the Department of Biomaterials at the University of Gothenburg, Sweden.

Swedish stem cell company Cellartis to be acquired by French biotech company Cellectis

2011-09-15 16:23 GöteborgBIO Cellartis AB, a premier provider of stem cell derived products and technologies, today announced that the company is to be acquired by the French biotech corporation Cellectis S.A. Cellartis AB was founded 2001 in Göteborg, Sweden, as a university spin-off and has developed a world-leading stem cell platform and products based on human pluripotent stem cells.